Hepatitis C Virus Infection And Metabolic Syndrome-A Community-Based Study in an Endemic Area of Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 25, Issue 6, 2009, Pages 299-305

  Huang, Jee Fu ^a,b   Chuang, Wan Long ^c,d   Yu, Ming Lung ^c,d   Yu, Sung Hua ^b   Huang, Chung Feng ^d   Huang, Ching I ^d   Yeh, Ming Lun ^d   Hsieh, Meng Hsuan ^a   Yang, Jeng Fu ^e   Lin, Zu Yau ^c,d   Chen, Shinn Chern ^c,d   Dai, Chia Yen ^c,d   Chang, Wen Yu ^d  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d Hepatobiliary Division   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

hepatitis C virus; insulin resistance; metabolic syndrome

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDEMIC DISEASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; SEROLOGY; TAIWAN; VIRUS HEPATITIS; WAIST CIRCUMFERENCE;

AGED; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; TAIWAN;

EID: 67651083550     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70520-0     Document Type: Article

References (31)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
2. Dai C.Y., Huang J.F., Hsieh M.Y., et al. Links between triglyceride levels, hepatitis C virus infection and diabetes. Gut 56 (2007) 1167-1168
3. Dai C.Y., Chuang W.L., Ho C.K., et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 49 (2008) 9-16
4. Siagris D., Christofidou M., Theocharis G.J., et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 13 (2006) 56-61
5. Hsieh M.H., Lee L.P., Hsieh M.Y., et al. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan. Jpn J Infect Dis 60 (2007) 377-381
6. Watanabe S., Yaginuma R., Ikejima K., et al. Liver diseases and metabolic syndrome. J Gastroenterol 43 (2008) 509-518
7. Sanyal A.J. Review article: non-alcoholic fatty liver disease and hepatitis C-risk factors and clinical implications. Aliment Pharmacol Ther 22 (2005) 48-51
8. Shintani Y., Fujie H., Miyoshi H., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
9. Huang J.F., Yu M.L., Dai C.Y., et al. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection. Am J Gastroenterol 103 (2008) 1933-1940
10. Camma C., Bruno S., Di Marco V., et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43 (2006) 64-71
11. Bressler B.L., Guindi M., Tomlinson G., et al. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 38 (2003) 639-644
12. Romero-Gomez M., Del Mar Viloria M., Andrade R.J., et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128 (2005) 636-641
13. Huang J.F., Lu S.N., Chue P.Y., et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect 127 (2001) 485-492
14. Lu S.N., Chue P.Y., Chen I.L., et al. Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci 13 (1997) 605-608
15. Chuang W.L., Yu M.L., Dai C.Y., et al. Treatment of chronic hepatitis C in southern Taiwan. Intervirology 49 (2006) 99-106
16. Anuurad E., Shiwaku K., Nogi A., et al. The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45 (2003) 335-343
17. Okamoto H., Tokita H., Sakamoto M., et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74 (1993) 2385-2390
18. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Carulli N. Metabolic syndrome-cardiovascular disease risk and more. Aliment Pharmacol Ther 22 (2005) 1-2
20. Shaheen M., Echeverry D., Oblad M.G., et al. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 75 (2007) 320-326
21. Moucari R., Marcellin P., and Asselah T. Steatosis during chronic hepatitis C: the role of insulin resistance and viral factors. Gastroenterol Clin Biol 31 (2007) 643-654
22. Tarantino G., Conca P., Sorrentino P., et al. Metabolic factors involved in the therapeutic response of patients with hepatitis C virus-related chronic hepatitis. J Gastroenterol Hepatol 21 (2006) 1266-1268
23. Sheikh M.Y., Choi J., Qadri I., et al. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 47 (2008) 2127-2133
24. Huang J.F., Dai C.Y., Hwang S.J., et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol 102 (2007) 1237-1243
25. Lecube A., Hernandez C., Genesca J., et al. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care 29 (2006) 1096-1101
26. Huang J.F., Chuang W.L., Dai C.Y., et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?. J Intern Med 260 (2006) 255-262
27. Huang J.F., Chuang W.L., Dai C.Y., et al. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy. J Viral Hepat 13 (2006) 396-401
28. Hadziyannis S.J. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 4 (1997) 9-28
29. Monazahian M., Bohme I., Bonk S., et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57 (1999) 223-229
30. Tada S., Saito H., Ebinuma H., et al. Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism. Hepatol Res 39 (2009) 195-199
31. Jensen M.D., Haymond M.W., Rizza R.A., et al. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83 (1989) 1168-1173